35例眼眶受侵鼻咽癌臨床分析
本文關(guān)鍵詞: 鼻咽癌 眼眶 受侵 出處:《廣西醫(yī)科大學(xué)》2014年碩士論文 論文類(lèi)型:學(xué)位論文
【摘要】:目的:通過(guò)回顧性分析35例診斷眼眶受侵鼻咽癌患者的資料,探討鼻咽癌眼眶受侵臨床特點(diǎn)。 方法:收集廣西醫(yī)科大學(xué)附屬腫瘤醫(yī)院2008年1月至2011年1月初治的診斷為眼眶受侵的鼻咽癌患者35例臨床資料,所有患者治療前均行詳細(xì)體格檢查、鼻咽及頸部CT或MRI檢查、鼻咽纖維鏡檢查、鼻咽腫物活檢及病理檢查等。閱讀患者病歷資料、影像學(xué)資料,隨訪至2014年2月,分析眼眶受侵鼻咽癌的臨床表現(xiàn)、影像學(xué)特點(diǎn)、主要侵犯途徑和治療結(jié)果,并探討影響其預(yù)后的因素。 結(jié)果: (1)鼻咽癌侵犯眼眶的發(fā)生率約3%。 (2)35例患者中,有視力下降者15例(占42.8%),有復(fù)視者有15例(占42.8%),有突眼者7例(占20%),有斜視者1例(占0.03%),眼瞼下垂者5例(占14%),,眼球固定者3例(占0.09%),瞳孔擴(kuò)大者1例(占0.03%),無(wú)光反射消失病例,出現(xiàn)眼痛者12例(占34%)。出現(xiàn)前組顱神經(jīng)損傷者有24例(占69%)。 (3)鼻咽癌侵犯到眼眶的途徑為:鼻咽—海綿竇—眶上裂或者眶尖(18/36);鼻咽—翼腭窩—眶下裂或者眶尖(14/36):鼻咽—篩竇—眶內(nèi)側(cè)壁(4/36)。 (4)影像學(xué)表現(xiàn):視神經(jīng)異常:9例(9只眼)。眼外肌異常8例。球后腫塊4例?艏饧翱舯诠琴|(zhì)異常28例。7例無(wú)骨質(zhì)破壞者,其中5例表現(xiàn)為眶上裂或眶下裂增寬,2例眶內(nèi)眼外肌或視神經(jīng)受侵,但眶上裂、眶下裂、視神經(jīng)孔無(wú)擴(kuò)大。 (5)全組患者1、2、3年生存率分別為97.1%、67.7%、50%?傮w轉(zhuǎn)移率約28.6%。 結(jié)論 (1)本組資料鼻咽癌侵犯眼眶發(fā)生率約3%。 (2)突眼、視力下降、復(fù)視、眼痛、眼瞼下垂為眼眶受侵最常見(jiàn)臨床表現(xiàn)。鼻咽癌侵犯到眼眶增加了顱神經(jīng)損傷風(fēng)險(xiǎn)。 (3)鼻咽癌侵犯到眼眶主要途徑為:1、鼻咽→海綿竇→眶上裂或者眶尖;2、鼻咽→翼腭窩→眶下裂或者眶尖:3、鼻咽→篩竇→眶內(nèi)側(cè)壁。 (4)眼眶受侵鼻咽癌侵犯范圍廣、顱神經(jīng)損傷多,預(yù)后較差,顱神經(jīng)損傷條數(shù)、有無(wú)化療為其獨(dú)立預(yù)后因素,放療技術(shù)應(yīng)首選三維調(diào)強(qiáng)放療。
[Abstract]:Objective: to investigate the clinical features of orbital invasion of nasopharyngeal carcinoma (NPC) by retrospective analysis of 35 cases of nasopharyngeal carcinoma (NPC). Methods: 35 cases of nasopharyngeal carcinoma with orbital invasion were collected from January 2008 to early January 2011 in affiliated Cancer Hospital of Guangxi Medical University. All patients underwent detailed physical examination, CT or MRI examination of nasopharynx and neck, nasopharyngeal fiberscope, nasopharyngeal mass biopsy and pathological examination before treatment. The clinical manifestations, imaging features, main invasion approaches and treatment results of orbital invasive nasopharyngeal carcinoma (NPC) were analyzed, and the prognostic factors were discussed. Results: The incidence of nasopharyngeal carcinoma invading orbit is about 3%. Of the 35 patients, 15 (42.8%) had vision loss, 15 (42.8%) had compound vision, 7 (20%) had protruding eyes. There were 1 case with strabismus (0.03%), 5 cases with blepharoptosis (14 cases), 3 cases with fixed eyeball (0.09%), 1 case (0.03%) with dilated pupil (0.03%). Eye pain occurred in 12 cases (34%) and anterior cranial nerve injury in 24 cases (69%). 3) nasopharyngeal carcinoma invades orbit through nasopharyngeal cavernous sinus-supraorbital fissure or orbital apex 18 / 36; Nasopharynx-pterygopalatine fossa-suborbital fissure or orbital apex 14 / 36: nasopharynx-ethmoid sinus-medial orbital wall 4 / 36. 4) Imaging findings: optic nerve abnormality in 9 cases, extraocular muscle abnormality in 8 cases, Retrobulbar mass in 4 cases, and orbital apex and orbital wall bone abnormality in 28 cases. In 5 cases, the supraorbital fissure or suborbital fissure was enlarged in 2 cases, but the supraorbital fissure, suborbital fissure and optic foramen were not enlarged. The survival rates of 1 and 3 years in the whole group were 97.1and 67.70.The overall metastasis rate was about 28.6%. Conclusion The incidence of nasopharyngeal carcinoma invading orbit was about 3%. The most common clinical manifestation of orbital invasion is oculomalgia, diplopia, ophthalmalgia and eyelid droop. The invasion of nasopharyngeal carcinoma into orbit increases the risk of cranial nerve injury. The main route of nasopharyngeal carcinoma invading orbit is 1: 1, nasopharynx. 鈫扖avernous sinus. 鈫扴upraorbital fissure or orbital apex 2, nasopharynx. 鈫扨terygopalatine. 鈫扴uborbital fissure or orbital apex: 3, nasopharynx. 鈫扙thmoid sinus. 鈫扢edial orbital wall. (4) Orbital invasion of nasopharyngeal carcinoma (NPC) was extensive, cranial nerve injury was more frequent, prognosis was poor, the number of cranial nerve injury strips, chemotherapy or not was its independent prognostic factor. Three-dimensional intensity modulated radiotherapy should be preferred for radiotherapy.
【學(xué)位授予單位】:廣西醫(yī)科大學(xué)
【學(xué)位級(jí)別】:碩士
【學(xué)位授予年份】:2014
【分類(lèi)號(hào)】:R739.63
【參考文獻(xiàn)】
相關(guān)期刊論文 前10條
1 管玉青,李衛(wèi)平;鼻咽癌262例頭痛癥狀分析[J];第一軍醫(yī)大學(xué)學(xué)報(bào);2001年07期
2 陳春燕;盧泰祥;;局部晚期鼻咽癌的放療化療聯(lián)合治療[J];國(guó)際腫瘤學(xué)雜志;2006年02期
3 練兵;王繼群;張偉軍;山艷春;;鼻咽癌眼部癥狀的臨床研究[J];臨床耳鼻咽喉頭頸外科雜志;2011年24期
4 李齡;王安宇;朱小東;謝東;吳春華;黃江瓊;楊超鳳;潘朝陽(yáng);;MRI與CT成像差異對(duì)鼻咽癌T分期以及原發(fā)腫瘤靶區(qū)體積影響的研究[J];臨床放射學(xué)雜志;2008年05期
5 鄭衛(wèi)權(quán),張雪林,陳龍華,劉杏元;鼻咽癌伴眶內(nèi)侵犯的CT診斷(附12例分析)[J];中國(guó)臨床醫(yī)學(xué)影像雜志;2000年05期
6 李佩蓮;周蘭蓀;吳照振;李振權(quán);;鼻咽癌的眼征[J];眼科學(xué)報(bào);1986年04期
7 孫穎,馬駿,黃瑩,唐玲瓏,李立,王巖,盧泰祥;鼻咽癌的CT與MRI對(duì)比研究[J];中國(guó)腫瘤臨床;2005年14期
8 龍晚生,王立,羅學(xué)毛;鼻咽癌眼眶浸潤(rùn)的臨床及MRI診斷[J];中華眼科雜志;2001年04期
9 鄒國(guó)榮;曹小龍;張超;謝方云;李濟(jì)時(shí);彭苗;;非轉(zhuǎn)移性T4期鼻咽癌的預(yù)后影響因素分析[J];腫瘤防治研究;2011年09期
10 王立俠;周純武;連世東;歐陽(yáng)漢;;鼻咽癌的MRI表現(xiàn)——附180例病例分析[J];中國(guó)醫(yī)學(xué)影像技術(shù);2006年06期
本文編號(hào):1479667
本文鏈接:http://sikaile.net/yixuelunwen/yank/1479667.html